Biblio Discovery — Demo Discovery Service

46 results for "Sebastian Dolff"

Showing 1–20 · 3.55 seconds · RSS

  1. Journal Article Full text

    A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice

    Frank Hanses; Sebastian Dolff; Janina Trauth et al.

    Antibiotics, Vol. 11 No. 5 · 2022 · English · DOAJ Scopus

    The antibiotic dalbavancin is approved for intravenous treatment of adults with acute bacterial skin and skin structure infections. This study aimed to observe the use, effectiveness, and safety of dalbavancin in clinical practice in Germany. It was a multicentre, prospective, and retrospective…

  2. Journal Article

    Intraperitoneal ampicillin treatment for peritoneal dialysis- related peritonitis with Listeria monocytogenes – a case report

    Kristina Boss; Ina Wiegard-Szramek; Jan Dziobaka et al.

    BMC Nephrology, Vol. 21 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background Peritoneal dialysis (PD)-related peritonitis is a rare but serious complication and is associated with increased morbidity and mortality rates. It is most commonly caused by Staphylococcus aureus or Staphylococcus epidermidis, but infection with Listeria monocytogenes may also…

  3. Journal Article

    IL-22 production of effector CD4+ T-cells is altered in SLE patients

    Sebastian Dolff; Claudia Scharpenberg; Christof Specker et al.

    European Journal of Medical Research, Vol. 24 No. 1 · 2019 · English · DOAJ Dropped by Scopus 2024

    Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by T-cell-dependent B-cell activation and altered T-cell response. Co-stimulatory and co-inhibitory molecules regulate and exert T-cell differentiation, survival and cytokine production. CD134+ and PD-1+…

  4. Journal Article

    Chloroquine Suppresses Effector B-Cell Functions and Has Differential Impact on Regulatory B-Cell Subsets

    Xin Ma; Yang Dai; Oliver Witzke et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    ObjectivesChloroquine (CQ) is approved for treatment of B-cell mediated diseases such as rheumatoid arthritis and systemic lupus erythematosus. However, the exact mode of action in these diseases has not been studied and it remains unclear which effect CQ has on B-cells. Thus, it was the aim of…

  5. Journal Article

    Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants

    Anja Gäckler; Sebastian Dolff; Hana Rohn et al.

    BMC Nephrology, Vol. 20 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background The influence of pre- or postprandial administration on pharmacokinetics of cyclosporine is supposed to be less in gel-based formulations than in microemulsions. This study was designed to investigate the influence of a high-fat meal on the pharmacokinetic profile of the two…

  6. Journal Article

    COVID-19 associated acute transplant failure after AB0-incompatible living donor kidney transplantation – a case report

    Kristina Boss; Margarethe Konik; Jan Hinrich Bräsen et al.

    BMC Nephrology, Vol. 24 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Introduction Immunosuppressive therapy is associated with an increased risk of severe courses of SARS-CoV-2 infection, with frequently delayed viral clearance. We report a case of an acute kidney transplant failure in persistent SARS-CoV-2 infection in a patient with absolute B-cell…

  7. Journal Article

    Separating the wheat from the chaff—COVID-19 in a German emergency department: a case-control study

    David Fistera; Dirk Pabst; Annalena Härtl et al.

    International Journal of Emergency Medicine, Vol. 13 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background COVID-19 pandemia is a major challenge to worldwide health care systems. Whereas the majority of disease presents with mild symptoms that can be treated as outpatients, severely ill COVID-19 patients and patients presenting with similar symptoms cross their ways in the emergency…

  8. Journal Article

    Long-term persistence of pneumococcal antibodies 5 years after a sequential PCV13 and PPSV23 vaccination in kidney transplant recipients: indications for revaccination

    Lukas van de Sand; Monika Lindemann; Kim L. Völk et al.

    mSphere, Vol. 11 No. 3 · 2026 · English · DOAJ Scopus

    ABSTRACT Pneumococcal vaccination is essential to prevent invasive Streptococcus pneumoniae infections in immunocompromised individuals, including kidney transplant recipients. Current recommendations favor single-dose immunization with higher-valent conjugate vaccines, including PCV20 or PCV21…

  9. Journal Article Full text

    Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19 + CD24 hi CD38 hi Regulatory B-Lymphocytes

    Bastian Tebbe; Benjamin Wilde; Zeng Ye et al.

    PLOS ONE, Vol. 11 No. 4 · 2016 · English · PLOS Scopus

    Background: CD19+CD24hiCD38hi transitional immature B-lymphocytes have been demonstrated to play an important role in regulating the alloimmune response in transplant recipients. Here, we analyzed the effect of calcineurin inhibition on these peripherally circulating regulatory B-cells (Breg) in…

    Also available at: DOAJ

  10. Journal Article Full text

    Reactivations of Latent Viral Infections Are Associated with an Increased Thr389 p70S6k Phosphorylation in Peripheral Lymphocytes of Renal Transplant Recipients

    Maxim Cherneha; Johannes Korth; Meike Kaulfuß et al.

    Viruses, Vol. 13 No. 3 · 2021 · English · DOAJ Scopus

    Reactivations of BK polyoma virus (BKPyV) and human cytomegalovirus (HCMV) frequently cause life- and graft-threatening complications after renal transplantation. Both viruses are dependent on the mTOR pathway for replication. In this study we investigated the association of viral replication with…

  11. Journal Article

    What about the others: differential diagnosis of COVID-19 in a German emergency department

    David Fistera; Annalena Härtl; Dirk Pabst et al.

    BMC Infectious Diseases, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background The ongoing COVID-19 pandemic remains a major challenge for worldwide health care systems and in particular emergency medicine. An early and safe triage in the emergency department (ED) is especially crucial for proper therapy. Clinical symptoms of COVID-19 comprise those of…

  12. Journal Article

    Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells

    Shilei Xu; Sebastian Dolff; Nils Mülling et al.

    Frontiers in Transplantation, Vol. 2 · 2023 · English · DOAJ Scopus

    ObjectivesFarnesyltransferase inhibitors (FTI), which inhibit the prenylation of Ras GTPases, were developed as anti-cancer drugs. As additional target proteins for prenylation were identified in the past, it is likely that FTI have potential value for therapeutic purposes beyond cancer. The effect…

  13. Journal Article

    Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected

    Alexandra Brinkhoff; Annette Sieberichs; Harald Engler et al.

    Frontiers in Immunology, Vol. 9 · 2018 · English · DOAJ Scopus

    ObjectiveSepsis is one of the leading causes of the deaths in hospitals. During sepsis, patients are exposed to endotoxemia, which may contribute to the dysregulation of the immune system frequently observed in sepsis. This dysregulation leads to impaired pro-inflammatory responses and may increase…

  14. Journal Article

    CD107a+ (LAMP-1) Cytotoxic CD8+ T-Cells in Lupus Nephritis Patients

    Anika Wiechmann; Benjamin Wilde; Bartosz Tyczynski et al.

    Frontiers in Medicine, Vol. 8 · 2021 · English · DOAJ Scopus

    Cytotoxic CD8+ T-cells play a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE). The aim of this study was to investigate the role of CD107a (LAMP-1) on cytotoxic CD8+ T-cells in SLE-patients in particular with lupus nephritis. Peripheral blood of SLE-patients (n = 31) and…

  15. Journal Article

    A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19

    Johanna Reinold; Farnoush Farahpour; Christian Fehring et al.

    Frontiers in Cellular and Infection Microbiology, Vol. 11 · 2021 · English · DOAJ Scopus

    The gut microbiota contributes to maintaining human health and regulating immune responses. Severe COVID-19 illness is associated with a dysregulated pro-inflammatory immune response. The effect of SARS-CoV-2 on altering the gut microbiome and the relevance of the gut microbiome on COVID-19…

  16. Journal Article Full text

    Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)

    Johannes Korth; Michael Jahn; Oliver Dorsch et al.

    Viruses, Vol. 13 No. 5 · 2021 · English · DOAJ Scopus

    The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has a major impact on transplant recipients, with mortality rates up to 20%. Therefore, the effect of established messenger RNA (mRNA)-based SARS-CoV-2 vaccines have to be evaluated for solid organ transplant patients (SOT) since they…

  17. Journal Article Full text

    Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis

    Michael Jahn; Johannes Korth; Oliver Dorsch et al.

    Vaccines, Vol. 9 No. 4 · 2021 · English · DOAJ Scopus

    mRNA-based SARS-CoV-2 vaccines offer a preventive strategy against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections that is of interest in the care of patients on hemodialysis (HDP). We measured humoral immune responses in 72 HDP after standard vaccination with two doses of…

  18. Journal Article

    The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients

    Johanna Reinold; Farnoush Farahpour; Ann-Kathrin Schoerding et al.

    Frontiers in Cellular and Infection Microbiology, Vol. 12 · 2022 · English · DOAJ Scopus

    Clinical and experimental studies indicate that the bacterial and fungal gut microbiota modulates immune responses in distant organs including the lungs. Immune dysregulation is associated with severe SARS-CoV-2 infection, and several groups have observed gut bacterial dysbiosis in SARS-CoV-2…